Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 5/2012

01.06.2012 | Original Article

Non-curative gastric resection for patients with stage 4 gastric cancer—a single center experience and current review of literature

verfasst von: Yves Dittmar, Falk Rauchfuss, Max Goetz, Karin Jandt, Hubert Scheuerlein, Michael Heise, Utz Settmacher

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The majority of patients with gastric cancer present with an advanced stage and, therefore, may not be eligible for curative treatment. The role of non-curative gastric resection in situations other than emergency treatment for life threatening tumor-related complications is still under discussion.

Methods

Data from 290 consecutive patients with advanced gastric cancer who were treated in our hospital were analyzed. A total of 48 patients underwent primary non-curative gastric resection.

Results

The overall survival in the non-curatively resected group was 15 months and 6 months for non-resected patients, respectively (p < 0.001). The incidence of tumor-related complications which required intervention was 63% in non-resected patients as compared to 12% in patients who underwent primary non-curative resection. Younger age, less than three tumor locations, and chemotherapy have been identified as prognostic factors for improved survival by univariate analysis. D3 lymph node involvement and chemotherapy were independent prognostic factors in the multivariate analysis. Peritoneal carcinosis did not significantly influence survival in resected patients. Non-curative resection in combination with chemotherapy resulted in longer overall survival than resection alone.

Conclusions

Primary non-curative gastric resection can reduce the incidence of severe tumor-related complications and can prolong overall survival in selected subgroups. In particular, younger patients with no more than two tumor locations should be considered for this procedure.
Literatur
1.
Zurück zum Zitat Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54(1):8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54(1):8–29PubMedCrossRef
3.
Zurück zum Zitat Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 63(2):364–367PubMedCrossRef Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 63(2):364–367PubMedCrossRef
4.
Zurück zum Zitat Feng XY, Chen YB, Chen S, Li YF, Zhou ZW, Li W, Zhan YQ, Sun XW, Xu DZ, Guan YX (2010) Relationship between the number of lymph node detection and prognosis in stage II( gastric cancer after D(2) dissection. Zhonghua Wei Chang Wai Ke Za Zhi 13(5):346–349PubMed Feng XY, Chen YB, Chen S, Li YF, Zhou ZW, Li W, Zhan YQ, Sun XW, Xu DZ, Guan YX (2010) Relationship between the number of lymph node detection and prognosis in stage II( gastric cancer after D(2) dissection. Zhonghua Wei Chang Wai Ke Za Zhi 13(5):346–349PubMed
5.
Zurück zum Zitat Hundahl SA, Phillips JL, Menck HR (2000) The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88(4):921–932. doi:10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-SPubMedCrossRef Hundahl SA, Phillips JL, Menck HR (2000) The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88(4):921–932. doi:10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-SPubMedCrossRef
7.
Zurück zum Zitat Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS (2004) Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 239(3):383–387PubMedCrossRef Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS (2004) Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 239(3):383–387PubMedCrossRef
8.
Zurück zum Zitat Shah MA, Kelsen DP (2010) Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 8(4):437–447PubMed Shah MA, Kelsen DP (2010) Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 8(4):437–447PubMed
12.
Zurück zum Zitat Lawrence W Jr, Mc NG (1958) The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11(1):28–32PubMedCrossRef Lawrence W Jr, Mc NG (1958) The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11(1):28–32PubMedCrossRef
13.
Zurück zum Zitat ReMine WH (1979) Palliative operations for incurable gastric cancer. World J Surg 3(6):721–729PubMedCrossRef ReMine WH (1979) Palliative operations for incurable gastric cancer. World J Surg 3(6):721–729PubMedCrossRef
14.
Zurück zum Zitat Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, Andreola S (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164(2):151–154PubMed Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, Andreola S (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164(2):151–154PubMed
16.
Zurück zum Zitat Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 134(2):187–192. doi:10.1007/s00432-007-0268-z PubMedCrossRef Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 134(2):187–192. doi:10.​1007/​s00432-007-0268-z PubMedCrossRef
17.
Zurück zum Zitat Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF Palliative resection in noncurative gastric cancer patients. World J Surg 34 (5):1015-1021. doi:10.1007/s00268-010-0467-7 Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF Palliative resection in noncurative gastric cancer patients. World J Surg 34 (5):1015-1021. doi:10.​1007/​s00268-010-0467-7
19.
20.
Zurück zum Zitat Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed
21.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2 PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196. doi:10.​1097/​SLA.​0b013e3181b13ca2​ PubMedCrossRef
22.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef
23.
Zurück zum Zitat Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Fujii S, Otsuka Y, Akiyama H, Ono HA, Kosaka T, Ichikawa Y, Shimada H (2008) Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. Anticancer Res 28(2B):1309–1315PubMed Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Fujii S, Otsuka Y, Akiyama H, Ono HA, Kosaka T, Ichikawa Y, Shimada H (2008) Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. Anticancer Res 28(2B):1309–1315PubMed
24.
Zurück zum Zitat Wang CS, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF (2002) Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J 25(12):792–802PubMed Wang CS, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF (2002) Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J 25(12):792–802PubMed
27.
Zurück zum Zitat Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69(1):41–44. doi:10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-KPubMedCrossRef Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69(1):41–44. doi:10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-KPubMedCrossRef
28.
Zurück zum Zitat Adachi Y, Aramaki M, Shiraishi N, Shimoda K, Yasuda K, Kitano S (1998) Long-term survival after perforation of advanced gastric cancer: case report and review of the literature. Gastric Cancer 1(1):80–83. doi:10.1007/s101209800024 PubMedCrossRef Adachi Y, Aramaki M, Shiraishi N, Shimoda K, Yasuda K, Kitano S (1998) Long-term survival after perforation of advanced gastric cancer: case report and review of the literature. Gastric Cancer 1(1):80–83. doi:10.​1007/​s101209800024 PubMedCrossRef
29.
Zurück zum Zitat Mizutani S, Shioya T, Maejima K, Yoshino M, Komine O, Bou H, Ogata M, Watanabe M, Shibuya T, Tokunaga A, Tajiri T (2007) Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis. J Nippon Med Sch 74(3):241–245CrossRef Mizutani S, Shioya T, Maejima K, Yoshino M, Komine O, Bou H, Ogata M, Watanabe M, Shibuya T, Tokunaga A, Tajiri T (2007) Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis. J Nippon Med Sch 74(3):241–245CrossRef
30.
Zurück zum Zitat Onate-Ocana LF, Mendez-Cruz G, Hernandez-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltran-Ortega A (2007) Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 10(4):215–220. doi:10.1007/s10120-007-0437-4 PubMedCrossRef Onate-Ocana LF, Mendez-Cruz G, Hernandez-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltran-Ortega A (2007) Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 10(4):215–220. doi:10.​1007/​s10120-007-0437-4 PubMedCrossRef
31.
Zurück zum Zitat Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP (2007) Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95(2):118–122. doi:10.1002/jso.20328 PubMedCrossRef Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP (2007) Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95(2):118–122. doi:10.​1002/​jso.​20328 PubMedCrossRef
32.
Zurück zum Zitat Nazli O, Yaman I, Tansug T, Isguder AS, Bozdag AD, Bolukbasi H (2007) Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma. Hepatogastroenterology 54(73):298–303PubMed Nazli O, Yaman I, Tansug T, Isguder AS, Bozdag AD, Bolukbasi H (2007) Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma. Hepatogastroenterology 54(73):298–303PubMed
35.
Zurück zum Zitat Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68(9):1863–1868PubMedCrossRef Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68(9):1863–1868PubMedCrossRef
36.
Zurück zum Zitat Meijer S, De Bakker OJ, Hoitsma HF (1983) Palliative resection in gastric cancer. J Surg Oncol 23(2):77–80PubMedCrossRef Meijer S, De Bakker OJ, Hoitsma HF (1983) Palliative resection in gastric cancer. J Surg Oncol 23(2):77–80PubMedCrossRef
37.
Zurück zum Zitat Yao Z, Mishra L (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8(18):1691–1698PubMedCrossRef Yao Z, Mishra L (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8(18):1691–1698PubMedCrossRef
38.
Zurück zum Zitat Tan S, Chen JS, Sun LJ, Yao HR (2009) Selective enrichment of hepatocellular cancer stem cells by chemotherapy. J Int Med Res 37(4):1046–1056PubMed Tan S, Chen JS, Sun LJ, Yao HR (2009) Selective enrichment of hepatocellular cancer stem cells by chemotherapy. J Int Med Res 37(4):1046–1056PubMed
39.
40.
Zurück zum Zitat Koller M, Kussmann J, Lorenz W, Rothmund M (1994) Measuring quality of life in after-care of tumor surgery. Methods, problems and applications. Chirurg 65(4):333–339PubMed Koller M, Kussmann J, Lorenz W, Rothmund M (1994) Measuring quality of life in after-care of tumor surgery. Methods, problems and applications. Chirurg 65(4):333–339PubMed
41.
Zurück zum Zitat Gilbertsen VA (1969) Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases. Cancer 23(6):1305–1308PubMedCrossRef Gilbertsen VA (1969) Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases. Cancer 23(6):1305–1308PubMedCrossRef
43.
Zurück zum Zitat Dittmar Y, Posorski N, Rauchfuss F, Voigt R, Heise M, Jandt K, Gajda M, Settmacher U (2010) Relationship between degree of chromosomal aberration and survival in intestinal-type gastric cancer—a preliminary report based on three cases of hepatic metastasized gastric cancer with long-time survival. Onkologie 33(11):591–596. doi:10.1159/000321143 PubMedCrossRef Dittmar Y, Posorski N, Rauchfuss F, Voigt R, Heise M, Jandt K, Gajda M, Settmacher U (2010) Relationship between degree of chromosomal aberration and survival in intestinal-type gastric cancer—a preliminary report based on three cases of hepatic metastasized gastric cancer with long-time survival. Onkologie 33(11):591–596. doi:10.​1159/​000321143 PubMedCrossRef
44.
Zurück zum Zitat Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21(4):233–248. doi:10.1002/ssu.10042 PubMedCrossRef Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21(4):233–248. doi:10.​1002/​ssu.​10042 PubMedCrossRef
45.
Zurück zum Zitat Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5. doi:10.1186/1477-7819-7-5 PubMedCrossRef Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5. doi:10.​1186/​1477-7819-7-5 PubMedCrossRef
46.
Zurück zum Zitat Iesalnieks I, Kullmann F, Dahlke M, Ghali N, Agha A, von Breitenbuch P, Schoelmerich J, Schlitt HJ, Piso P (2006) Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin. Z Gastroenterol 44(12):1237–1245. doi:10.1055/s-2006-927156 PubMedCrossRef Iesalnieks I, Kullmann F, Dahlke M, Ghali N, Agha A, von Breitenbuch P, Schoelmerich J, Schlitt HJ, Piso P (2006) Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin. Z Gastroenterol 44(12):1237–1245. doi:10.​1055/​s-2006-927156 PubMedCrossRef
47.
Zurück zum Zitat Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374PubMedCrossRef Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374PubMedCrossRef
Metadaten
Titel
Non-curative gastric resection for patients with stage 4 gastric cancer—a single center experience and current review of literature
verfasst von
Yves Dittmar
Falk Rauchfuss
Max Goetz
Karin Jandt
Hubert Scheuerlein
Michael Heise
Utz Settmacher
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 5/2012
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-012-0902-3

Weitere Artikel der Ausgabe 5/2012

Langenbeck's Archives of Surgery 5/2012 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.